In his own words:

"The Lancet Commission is a call to action: to turn evidence into equity, and to walk the Magere Brug (narrow path) toward medicines justice."

A pharmacist and global medicines policy expert, Andy co-chairs the Lancet Commission on Accelerating Progress on Essential Medicines (2025–2027). With decades of experience in pharmaceutical policy, regulation, and access, he also leads research and capacity building at the WHO Collaborating Centre on Pharmaceutical Policy and is a Senior Lecturer at the University of KwaZulu-Natal.

📅 Join us to hear her insights at the Medicines Justice Conference (28-29 October 2025)
 🔗 Programme: https://lnkd.in/etKKnhvt 
📝 Registration: https://lnkd.in/eMcXJYeX

Full bio of Dr. Andy Gray:

Andy Gray BPharm, MSc (Pharm), PhD, FPS, FFIP  is a pharmacist whose research interests include policy analysis (in particular, the development and implementation of National Medicines Policies), rational medicines use and the application of antiretroviral therapy in resource-constrained settings. He is a Senior Lecturer in the Division of Pharmacology, Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. He is co-director of the WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice. He was appointed to the South African National Essential Medicines List Committee in 2013. He is currently chair of the Names and Scheduling Committee of the South African Health Products Regulatory Authority (SAHPRA) and serves on its Legal Committee and Pharmacovigilance Committee. He is a Member of the World Health Organization’s Expert Panel on Drug Policies and Management and has served as a member, rapporteur and co-chairperson of the Expert Committee on the Selection and Use of Essential Medicines, as chairperson of the sub-committee on Essential Medicines for Children, and on the WHO Guidelines Review Committee. He has served as a Co-Chair of the Lancet Commission on Essential Medicines for Universal Health Coverage (2017) and is a Co-Chair of the Lancet Commission on Accelerating Progress on Essential Medicines (2025-2027).